<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01817127</url>
  </required_header>
  <id_info>
    <org_study_id>216198</org_study_id>
    <nct_id>NCT01817127</nct_id>
  </id_info>
  <brief_title>Elucidation of Breast Milk Composition and Structure Over the First Year of Lactation: UC Davis Lactation Study</brief_title>
  <official_title>Functional Deconstruction of Human Milk Oligosaccharides and Lipids</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Davis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>California Dairy Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, Davis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This observational study is designed to determine how sugars, lipids and proteins in breast
      milk vary among mothers; is affected by maternal diet, health and microbiota and vary over
      the course of lactation. Additionally, the study is designed to determine how the structure
      and composition of complex milk sugars, maternal health status and diet influence the
      development and maintenance of infant gut microflora.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study's objectives include: 1) develop a better understanding of the composition and
      structures of breast milk over the early stages of lactation with specific emphasis on the
      glycans and lipids; 2) how glycan diversity relates to maternal and infant gut microbiota
      with an emphasis on bifidobacteria species; 3)how milk composition and structure relate to
      maternal health and diet.

      These samples will be analyzed using comprehensive gas and liquid chromatographic methods,
      nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS); and next generation
      sequencing, terminal restriction fragment length polymorphism and quantitative polymerase
      chain reaction.

      There are several cohorts to the main study.

      Gestational Diabetes Mellitus Cohort. The aim of this study is to investigate the differences
      between milk composition, infant and maternal gut microbiota from women with and without
      gestational diabetes mellitus or type 2 diabetes vs. controls.

      Fresh Milk Study. The aim of this study is to elucidate the relationship between the
      expression of glycan metabolizing genes of mammary epithelial cells and levels of milk
      glycans.

      RNA Study. The aim of this study is to compare the RNA of milk fat globule membrane crescents
      in human milk against epithelial expression profiles in non-human primate milk.

      Skin Study. The aim of this study is to provide skin samples from healthy term infants to act
      as the control group for a different study with preterm infants.

      Breast Milk, Gut Microbiome, and Immunity (BMMI) Project. The aim of this study is to provide
      healthy control samples for the BMMI project. The BMMI project is a multi-investigative
      project designed to elucidate how maternal nutrient status, and milk composition and
      structure influence infant gut microbiome from participants in developing countries.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 2009</start_date>
  <completion_date type="Anticipated">October 29, 2018</completion_date>
  <primary_completion_date type="Anticipated">October 29, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Human milk glycans</measure>
    <time_frame>Change from day 2 to day 366</time_frame>
    <description>Human milk glycans: human milk oligosaccharides and glycoconjugates to lipids, proteins and peptides will be measured by MS methods.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Microbiota</measure>
    <time_frame>3rd trimester pregnancy and Day 2-Day 366 postpartum</time_frame>
    <description>Maternal and infant gut microbiota, infant skin microbiota will be measured using next generation sequencing, terminal restriction fragment length polymorphism and quantitative polymerase chain reaction.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proteome</measure>
    <time_frame>Day 2-Day 366 postpartum</time_frame>
    <description>Milk and infant stratum corneum will be analyzed by MS methods.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lipidome</measure>
    <time_frame>Day 2-Day 366 postpartum</time_frame>
    <description>Milk and skin will be analyzed by gas chromatography and MS methods.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal plasma lipids</measure>
    <time_frame>3rd trimester pregnancy and 2 months postpartum</time_frame>
    <description>The plasma lipid profile will be analyzed by enzyme assay by UC Davis Pathology Lab.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peptidome</measure>
    <time_frame>3rd trimester pregnancy and Day 2-Day 366</time_frame>
    <description>Milk and infant and maternal stool will be analyzed by MS methods.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolome by Nuclear Magnetic Spectroscopy (NMR)</measure>
    <time_frame>3rd trimester of pregnancy and D2-Day 366</time_frame>
    <description>Milk, maternal and infant urine and stool will be analyzed by NMR spectroscopy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolome by MS</measure>
    <time_frame>Day 2-Day 366 postpartum</time_frame>
    <description>Milk, maternal and infant urine and stool will be analyzed by MS.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secretor status genotyping</measure>
    <time_frame>3rd trimester pregnancy and Day 60 postpartum</time_frame>
    <description>Maternal secretor status genotyping will be determined by quantitative polymerase chain reaction for the functional fucosyltransferase 2 gene from maternal saliva.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal fasting and postprandial blood sugar</measure>
    <time_frame>3rd trimester of pregnancy and Day 3-7</time_frame>
    <description>Maternal blood sugar will be checked by finger stick using a glucometer in women diagnosed with gestational diabetes mellitus.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal plasma lipoprotein size distribution</measure>
    <time_frame>3rd trimester of pregnancy and Day 60 postpartum</time_frame>
    <description>Plasma lipoprotein size distribution and concentration will be analyzed by NMR spectroscopy by LipoScience.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Human Milk Transcriptomics</measure>
    <time_frame>3 and 6 months postpartum</time_frame>
    <description>Milk samples will be preserved with RNA-later, RNA extracted and analyzed by next generation sequencing techniques.</description>
  </secondary_outcome>
  <number_of_groups>6</number_of_groups>
  <enrollment type="Actual">395</enrollment>
  <condition>Healthy</condition>
  <condition>Gestational Diabetes Mellitus</condition>
  <condition>Type 2 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Main Study</arm_group_label>
    <description>Women enrolled in this cohort of the study will collect their breast milk, infant urine and stool, and their urine and stool samples. Blood and saliva will be collected from these participants by study personnel.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Gestational Diabetes Mellitus Cohort</arm_group_label>
    <description>Women who have been diagnosed with gestational diabetes mellitus, type 2 diabetes mellitus or impaired glucose tolerance will be enrolled in this cohort. Participants will be asked to report their fasting and postprandial blood glucose levels if they are monitoring these outcomes at home with a glucometer.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fresh Milk Cohort</arm_group_label>
    <description>Women enrolled in this cohort will provide fresh milk samples (stored in the refrigerator and picked up by study personnel within 1 hour of collection) for analysis of glycan composition and gene expression of glycan metabolizing enzymes of somatic cells in milk.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RNA Milk Fat Cohort</arm_group_label>
    <description>Women enrolled in this cohort must have given birth to sons and will collect a fresh milk sample for transcriptomic analysis compared against non-human primate milk.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Skin Study</arm_group_label>
    <description>This cohort includes mothers and their infants who will provide milk and infant stratum corneum cells to act as the control group for a different study designed to investigate skin function in premature infants.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BMMI Project</arm_group_label>
    <description>Subjects enrolled in this cohort will be part of the control group for the BMMI Project.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Breast milk, blood, saliva, urine, stool, epidermal skin cells
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy pregnant women and women diagnosed with gestational diabetes mellitus or type 2
        diabetes mellitus.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant women 18 years and older who plan to breastfeed for at least 6 months

          -  Women who are in good health

          -  Women with or without diagnosis of gestational diabetes mellitus, or type 2 diabetes
             mellitus or impaired glucose tolerance

        Exclusion Criteria:

          -  Women who do not plan to breastfeed for at least 6 months

          -  Women who give birth to pre-term infants

          -  Women who smoke, either currently or 1 year before becoming pregnant

          -  Women who have chronic medical conditions or communicable diseases

          -  Women who take metabolic altering drugs such as corticosteroids or thyroid medication
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bruce German, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Davis</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carlito Lebrilla, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Davis</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Mills, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Davis</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bart Weimer, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Davis</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xiangdong Wu, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Davis</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Helen Raybould, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Davis</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jennifer T. Smilowitz, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Davis</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Danielle Lemay, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Davis</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California, Davis</name>
      <address>
        <city>Davis</city>
        <state>California</state>
        <zip>95616</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://ffhi.ucdavis.edu/human-studies/lactation-study-1</url>
    <description>Details for this research project is available through the UC Davis Foods for Health Institute website</description>
  </link>
  <reference>
    <citation>Totten SM, Zivkovic AM, Wu S, Ngyuen U, Freeman SL, Ruhaak LR, Darboe MK, German JB, Prentice AM, Lebrilla CB. Comprehensive profiles of human milk oligosaccharides yield highly sensitive and specific markers for determining secretor status in lactating mothers. J Proteome Res. 2012 Dec 7;11(12):6124-33. doi: 10.1021/pr300769g. Epub 2012 Nov 19.</citation>
    <PMID>23140396</PMID>
  </reference>
  <reference>
    <citation>De Leoz ML, Gaerlan SC, Strum JS, Dimapasoc LM, Mirmiran M, Tancredi DJ, Smilowitz JT, Kalanetra KM, Mills DA, German JB, Lebrilla CB, Underwood MA. Lacto-N-tetraose, fucosylation, and secretor status are highly variable in human milk oligosaccharides from women delivering preterm. J Proteome Res. 2012 Sep 7;11(9):4662-72. doi: 10.1021/pr3004979. Epub 2012 Aug 28.</citation>
    <PMID>22900748</PMID>
  </reference>
  <reference>
    <citation>Neville MC, Anderson SM, McManaman JL, Badger TM, Bunik M, Contractor N, Crume T, Dabelea D, Donovan SM, Forman N, Frank DN, Friedman JE, German JB, Goldman A, Hadsell D, Hambidge M, Hinde K, Horseman ND, Hovey RC, Janoff E, Krebs NF, Lebrilla CB, Lemay DG, MacLean PS, Meier P, Morrow AL, Neu J, Nommsen-Rivers LA, Raiten DJ, Rijnkels M, Seewaldt V, Shur BD, VanHouten J, Williamson P. Lactation and neonatal nutrition: defining and refining the critical questions. J Mammary Gland Biol Neoplasia. 2012 Jun;17(2):167-88. doi: 10.1007/s10911-012-9261-5. Epub 2012 Jul 1.</citation>
    <PMID>22752723</PMID>
  </reference>
  <reference>
    <citation>Garrido D, Nwosu C, Ruiz-Moyano S, Aldredge D, German JB, Lebrilla CB, Mills DA. Endo-β-N-acetylglucosaminidases from infant gut-associated bifidobacteria release complex N-glycans from human milk glycoproteins. Mol Cell Proteomics. 2012 Sep;11(9):775-85. doi: 10.1074/mcp.M112.018119. Epub 2012 Jun 27.</citation>
    <PMID>22745059</PMID>
  </reference>
  <reference>
    <citation>Sela DA, Garrido D, Lerno L, Wu S, Tan K, Eom HJ, Joachimiak A, Lebrilla CB, Mills DA. Bifidobacterium longum subsp. infantis ATCC 15697 α-fucosidases are active on fucosylated human milk oligosaccharides. Appl Environ Microbiol. 2012 Feb;78(3):795-803. doi: 10.1128/AEM.06762-11. Epub 2011 Dec 2.</citation>
    <PMID>22138995</PMID>
  </reference>
  <reference>
    <citation>Marcobal A, Barboza M, Sonnenburg ED, Pudlo N, Martens EC, Desai P, Lebrilla CB, Weimer BC, Mills DA, German JB, Sonnenburg JL. Bacteroides in the infant gut consume milk oligosaccharides via mucus-utilization pathways. Cell Host Microbe. 2011 Nov 17;10(5):507-14. doi: 10.1016/j.chom.2011.10.007. Epub 2011 Oct 27.</citation>
    <PMID>22036470</PMID>
  </reference>
  <reference>
    <citation>Froehlich JW, Barboza M, Chu C, Lerno LA Jr, Clowers BH, Zivkovic AM, German JB, Lebrilla CB. Nano-LC-MS/MS of glycopeptides produced by nonspecific proteolysis enables rapid and extensive site-specific glycosylation determination. Anal Chem. 2011 Jul 15;83(14):5541-7. doi: 10.1021/ac2003888. Epub 2011 Jun 28.</citation>
    <PMID>21661761</PMID>
  </reference>
  <reference>
    <citation>Sela DA, Li Y, Lerno L, Wu S, Marcobal AM, German JB, Chen X, Lebrilla CB, Mills DA. An infant-associated bacterial commensal utilizes breast milk sialyloligosaccharides. J Biol Chem. 2011 Apr 8;286(14):11909-18. doi: 10.1074/jbc.M110.193359. Epub 2011 Feb 2. Erratum in: J Biol Chem. 2011 Jul 1;286(26):23620.</citation>
    <PMID>21288901</PMID>
  </reference>
  <reference>
    <citation>Nwosu CC, Strum JS, An HJ, Lebrilla CB. Enhanced detection and identification of glycopeptides in negative ion mode mass spectrometry. Anal Chem. 2010 Dec 1;82(23):9654-62. doi: 10.1021/ac101856r. Epub 2010 Nov 4.</citation>
    <PMID>21049935</PMID>
  </reference>
  <reference>
    <citation>Zivkovic AM, German JB, Lebrilla CB, Mills DA. Human milk glycobiome and its impact on the infant gastrointestinal microbiota. Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4653-8. doi: 10.1073/pnas.1000083107. Epub 2010 Aug 2.</citation>
    <PMID>20679197</PMID>
  </reference>
  <reference>
    <citation>Froehlich JW, Dodds ED, Barboza M, McJimpsey EL, Seipert RR, Francis J, An HJ, Freeman S, German JB, Lebrilla CB. Glycoprotein expression in human milk during lactation. J Agric Food Chem. 2010 May 26;58(10):6440-8. doi: 10.1021/jf100112x.</citation>
    <PMID>20415418</PMID>
  </reference>
  <reference>
    <citation>Marcobal A, Barboza M, Froehlich JW, Block DE, German JB, Lebrilla CB, Mills DA. Consumption of human milk oligosaccharides by gut-related microbes. J Agric Food Chem. 2010 May 12;58(9):5334-40. doi: 10.1021/jf9044205.</citation>
    <PMID>20394371</PMID>
  </reference>
  <reference>
    <citation>Ninonuevo MR, Ward RE, LoCascio RG, German JB, Freeman SL, Barboza M, Mills DA, Lebrilla CB. Methods for the quantitation of human milk oligosaccharides in bacterial fermentation by mass spectrometry. Anal Biochem. 2007 Feb 1;361(1):15-23. Epub 2006 Nov 27.</citation>
    <PMID>17181994</PMID>
  </reference>
  <reference>
    <citation>Locascio RG, Niñonuevo MR, Kronewitter SR, Freeman SL, German JB, Lebrilla CB, Mills DA. A versatile and scalable strategy for glycoprofiling bifidobacterial consumption of human milk oligosaccharides. Microb Biotechnol. 2009 May;2(3):333-42. doi: 10.1111/j.1751-7915.2008.00072.x. Epub 2008 Dec 5.</citation>
    <PMID>21261928</PMID>
  </reference>
  <reference>
    <citation>Niñonuevo MR, Perkins PD, Francis J, Lamotte LM, LoCascio RG, Freeman SL, Mills DA, German JB, Grimm R, Lebrilla CB. Daily variations in oligosaccharides of human milk determined by microfluidic chips and mass spectrometry. J Agric Food Chem. 2008 Jan 23;56(2):618-26. Epub 2007 Dec 19.</citation>
    <PMID>18088092</PMID>
  </reference>
  <reference>
    <citation>LoCascio RG, Ninonuevo MR, Freeman SL, Sela DA, Grimm R, Lebrilla CB, Mills DA, German JB. Glycoprofiling of bifidobacterial consumption of human milk oligosaccharides demonstrates strain specific, preferential consumption of small chain glycans secreted in early human lactation. J Agric Food Chem. 2007 Oct 31;55(22):8914-9. Epub 2007 Oct 5.</citation>
    <PMID>17915960</PMID>
  </reference>
  <reference>
    <citation>Ninonuevo MR, Park Y, Yin H, Zhang J, Ward RE, Clowers BH, German JB, Freeman SL, Killeen K, Grimm R, Lebrilla CB. A strategy for annotating the human milk glycome. J Agric Food Chem. 2006 Oct 4;54(20):7471-80.</citation>
    <PMID>17002410</PMID>
  </reference>
  <reference>
    <citation>Chu CS, Niñonuevo MR, Clowers BH, Perkins PD, An HJ, Yin H, Killeen K, Miyamoto S, Grimm R, Lebrilla CB. Profile of native N-linked glycan structures from human serum using high performance liquid chromatography on a microfluidic chip and time-of-flight mass spectrometry. Proteomics. 2009 Apr;9(7):1939-51. doi: 10.1002/pmic.200800249.</citation>
    <PMID>19288519</PMID>
  </reference>
  <reference>
    <citation>Hong P, Ninonuevo MR, Lee B, Lebrilla C, Bode L. Human milk oligosaccharides reduce HIV-1-gp120 binding to dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN). Br J Nutr. 2009 Feb;101(4):482-6.</citation>
    <PMID>19230080</PMID>
  </reference>
  <reference>
    <citation>Lewis ZT, Bokulich NA, Kalanetra KM, Ruiz-Moyano S, Underwood MA, Mills DA. Use of bifidobacterial specific terminal restriction fragment length polymorphisms to complement next generation sequence profiling of infant gut communities. Anaerobe. 2013 Feb;19:62-9. doi: 10.1016/j.anaerobe.2012.12.005. Epub 2012 Dec 20.</citation>
    <PMID>23261904</PMID>
  </reference>
  <reference>
    <citation>Garrido D, Ruiz-Moyano S, Jimenez-Espinoza R, Eom HJ, Block DE, Mills DA. Utilization of galactooligosaccharides by Bifidobacterium longum subsp. infantis isolates. Food Microbiol. 2013 Apr;33(2):262-70. doi: 10.1016/j.fm.2012.10.003. Epub 2012 Oct 22.</citation>
    <PMID>23200660</PMID>
  </reference>
  <reference>
    <citation>Gordon JI, Dewey KG, Mills DA, Medzhitov RM. The human gut microbiota and undernutrition. Sci Transl Med. 2012 Jun 6;4(137):137ps12. doi: 10.1126/scitranslmed.3004347.</citation>
    <PMID>22674549</PMID>
  </reference>
  <reference>
    <citation>Garrido D, Ruiz-Moyano S, Mills DA. Release and utilization of N-acetyl-D-glucosamine from human milk oligosaccharides by Bifidobacterium longum subsp. infantis. Anaerobe. 2012 Aug;18(4):430-5. doi: 10.1016/j.anaerobe.2012.04.012. Epub 2012 May 9.</citation>
    <PMID>22579845</PMID>
  </reference>
  <reference>
    <citation>Chichlowski M, De Lartigue G, German JB, Raybould HE, Mills DA. Bifidobacteria isolated from infants and cultured on human milk oligosaccharides affect intestinal epithelial function. J Pediatr Gastroenterol Nutr. 2012 Sep;55(3):321-7. doi: 10.1097/MPG.0b013e31824fb899.</citation>
    <PMID>22383026</PMID>
  </reference>
  <reference>
    <citation>Garrido D, Kim JH, German JB, Raybould HE, Mills DA. Oligosaccharide binding proteins from Bifidobacterium longum subsp. infantis reveal a preference for host glycans. PLoS One. 2011 Mar 15;6(3):e17315. doi: 10.1371/journal.pone.0017315.</citation>
    <PMID>21423604</PMID>
  </reference>
  <reference>
    <citation>Barboza M, Sela DA, Pirim C, Locascio RG, Freeman SL, German JB, Mills DA, Lebrilla CB. Glycoprofiling bifidobacterial consumption of galacto-oligosaccharides by mass spectrometry reveals strain-specific, preferential consumption of glycans. Appl Environ Microbiol. 2009 Dec;75(23):7319-25. doi: 10.1128/AEM.00842-09. Epub 2009 Oct 2.</citation>
    <PMID>19801485</PMID>
  </reference>
  <results_reference>
    <citation>Barboza M, Pinzon J, Wickramasinghe S, Froehlich JW, Moeller I, Smilowitz JT, Ruhaak LR, Huang J, Lönnerdal B, German JB, Medrano JF, Weimer BC, Lebrilla CB. Glycosylation of human milk lactoferrin exhibits dynamic changes during early lactation enhancing its role in pathogenic bacteria-host interactions. Mol Cell Proteomics. 2012 Jun;11(6):M111.015248. doi: 10.1074/mcp.M111.015248. Epub 2012 Jan 19.</citation>
    <PMID>22261723</PMID>
  </results_reference>
  <results_reference>
    <citation>Dallas DC, Martin WF, Strum JS, Zivkovic AM, Smilowitz JT, Underwood MA, Affolter M, Lebrilla CB, German JB. N-linked glycan profiling of mature human milk by high-performance microfluidic chip liquid chromatography time-of-flight tandem mass spectrometry. J Agric Food Chem. 2011 Apr 27;59(8):4255-63. doi: 10.1021/jf104681p. Epub 2011 Mar 18.</citation>
    <PMID>21384928</PMID>
  </results_reference>
  <results_reference>
    <citation>Argov-Argaman N, Smilowitz JT, Bricarello DA, Barboza M, Lerno L, Froehlich JW, Lee H, Zivkovic AM, Lemay DG, Freeman S, Lebrilla CB, Parikh AN, German JB. Lactosomes: structural and compositional classification of unique nanometer-sized protein lipid particles of human milk. J Agric Food Chem. 2010 Nov 10;58(21):11234-42. doi: 10.1021/jf102495s. Epub 2010 Oct 6.</citation>
    <PMID>20925428</PMID>
  </results_reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 11, 2013</study_first_submitted>
  <study_first_submitted_qc>March 19, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 22, 2013</study_first_posted>
  <last_update_submitted>March 23, 2018</last_update_submitted>
  <last_update_submitted_qc>March 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Diabetes, Gestational</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

